Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis
Clinical trial NCT04560790 · COMPLETED
Trial details
- NCT number
- NCT04560790
- Sponsor
- Shanghai BDgene Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2022-07-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.